AQST Operating Income

Aquestive Therapeutics Inc · Operating Income

AQST logo

AQST Operating Income

Latest reported-$52.75M
AQST TTM Operating Income (-$113.00K → -$52.75M)
High-resolution chart · PNG

AQST operating income history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aquestive Therapeutics Inc Operating Income — Trailing twelve months (TTM) (USD)
Period endingOperating Income (USD)
-52,745,000
-55,890,000
-71,051,000
-55,791,000
-52,602,000
-41,179,000
-30,771,000
-21,103,000
-15,190,000
-19,454,000
-15,102,000
-21,904,000
-28,380,000
-36,933,000
-42,066,000
-43,022,000
-42,137,000
-35,892,000
-34,679,000
-38,656,000
-44,469,000
-37,557,000
-42,893,000
-37,151,000
-34,372,000
-53,455,000
-52,668,000
-55,113,000
-53,315,000
-67,313,000
-48,934,000
-43,841,000
-24,216,000
4,411,000
-113,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.